Cingulate Announces Phase 3 CTx-1301 ADHD Data Published In Journal Of Child And Adolescent Psychopharmacology, With Placebo-Adjusted Effect Sizes Of 0.737 To 1.185

뉴스 본문을 불러오고 있어요.

Cingulate Announces Phase 3 CTx-1301 ADHD Data Published In Journal Of Child And Adolescent Psychopharmacology, With Placebo-Adjusted Effect Sizes Of 0.737 To 1.185 | 웨이프 WAPE

Cingulate Announces Phase 3 CTx-1301 ADHD Data Published In Journal Of Child And Adolescent Psychopharmacology, With Placebo-Adjusted Effect Sizes Of 0.737 To 1.185

기사 요약

관련 종목

댓글 —